Restrictive approach to blood cell transfusions safe for heart surgery patients
In a recent clinical trial of higher risk patients undergoing cardiopulmonary bypass surgery, a restrictive approach to blood cell transfusions resulted in fewer transfusions without putting patients at increased risk of acute kidney injury. The results were consistent in patients with and without chronic kidney disease before surgery. The study is published online June 20, 2019 in the Journal of the American Society of Nephrology.
Read the full story.
Create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies